AODtraining@MHC – Register Now
AODtraining@MHC - Register Now
The Semester 1 2023 AODtraining@MHC and AODwebinars@MHC calendars are now open for registrations. Both calendars include new alcohol and other drug training events as well as popular and foundational events – please see the below lists for a sample.
NEW
- ST345 Trauma Informed Care and Practice with young people
- From MDMA to Psilocybin: What is Substance-Assisted Psychotherapy? (webinar)
- Supporting sustained behaviour change over time (relapse prevention) (webinar)
- Working with young people with co-occurring mental health and alcohol and other drug issues (webinar)
POPULAR
- KA/ST027 Ways of working with Aboriginal people – Part 1
- ST284 Motivational Interviewing – Part 1
- ST326 Trauma Informed Care and Practice
- ST343 Emotion Regulation
- An introduction to coercive control (webinar)
- An introduction to emotion regulation (webinar)
FOUNDATIONAL
- ST284 Motivational interviewing part 1
- ST222 Induction training for new AOD workers
- ST334 AOD skills foundation
- ST338 Working with clients who use AOD with co-occurring mental health issues
For further information and to register head to the AODtraining@MHC calendar or the AODwebinars@MHC calendar.
If you are not able to make it to training, MHC also has a variety of online learning programs available. Topics include Introduction to alcohol and other drugs, Opioid overdose and the use of naloxone, AOD prevention, and Needle and syringe programs.
Sector News and Events
FYI E-Newsletter March 2024
Find out what the WANADA team is working on and read all the latest news for the WA alcohol and other drug sector in FYI.
Cultural Diversity Benefits WANADA
Turkish, Spanish, German and French are all languages fluently spoken by members of the WANADA team.
Training for certification success
Twenty-one participants from the Aboriginal community controlled sector across WA completed lead auditor training in September.
Opioid Dependence Treatment Program – Pharmaceutical Benefits Scheme Changes
From 1 July 2023, Opioid Dependence Treatment medicines will become part of the Section 100 Highly Specialised Drugs (HSD) Program (Community Access) arrangements. Find out what this means for you.